TAVIperipheral arterial diseaseNetherlands Heart RegistrationIn-hospital strokeStroke
…study using data from the Netherlands Heart Registration of all TAVI procedures performed in the Netherlands between 2013 and 2023. …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,021–1,080 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
monoclonal antibodies2nephrectomy2neuromuscular electrical stimulation2neurorehabilitation2new treatments2non-pharmacological strategies2nucleos(t)ide analogue therapy2oncological treatments2open heart surgery2optimal treatment2oral supplementation2orthodontic treatment2palliative medicine2panretinal photocoagulation2perioperative chemotherapy2pharmaceutical interventions2pharmacological and surgical treatments2pharmacological cardioversion2photobiomodulation therapy2platinum-doublet chemotherapy2postexposure prophylaxis2potassium supplementation2pre-operative chemotherapy2preventive interventions2preventive treatments2psychoeducation2radioiodine therapy2red blood cell transfusion2renal artery embolisation2reperfusion therapies2respiratory support2root canal treatment2second-line chemotherapy2septal reduction therapy2shunting2silicone oil tamponade2single antiplatelet therapy2small bowel resection2smoking cessation2spinal surgery2standard medical management2stellate ganglion block2stent2stent assisted coiling2stereotactic radiosurgery2stereotactic radiotherapy2sulfonylurea therapy2supplemental oxygen therapy2supplementation2surgeries2surgical procedures2surgical repair2symptom management2systemic antibiotics2targeted antibiotic therapy2targeted interventions2therapeutic management2therapeutic plasma exchange2thyroid hormone replacement2topical corticosteroids2
Articles mentioning treatments
7,227 articles · page 41 of 603immunotherapybispecific T-cell engager therapyCancer Genome Atlas Research Network
…rating public and real-world multi-omics datasets to accelerate immunotherapy target discovery and validation across solid and hematological …
immunotherapyICIsNSCLCNorthwestern University
…en JBAG, Blank CU, Beets-Tan RGH. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. Ann Oncol. 2019; 30:998–…
immunotherapyimmunotherapies
… remain underexplored. This study evaluates trends in inpatient immunotherapy use, outcomes, and resource utilization using a large, national…
ICI rechallengemccRCCnivolumabpembrolizumabcabozantiniblenvatinibipilimumabaxitinib
…5) (figure 1).Conclusions Our results outline opportunities for ICI rechallenge, regardless of the prior immunotherapy administered. Improved o…
91.3%
PD-1 immunotherapycombination immunotherapyimmunotherapyUniversity of California IrvinemelanomanivolumabChao Family Comprehensive Cancer CenteripilimumabαPD-1
…Background PD-1 immunotherapy revolutionized cancer treatment since its approval in 2014 but …
immunotherapyHNSCCMount Sinai Institutional BiorepositoryHead and neck squamous cell carcinoma (HNSCC)Mount Sinai PPHS IRB
… largest HNSCC SCRNAseq cohort to date. Preliminary findings in immunotherapy resistant tumors compared to treatment-naïve HNSCC revealed dif…
immunotherapySABRBSCgalcisplatinmalignant cancersHNCcanine head and neck cancerPD-1 inhibitors
… therapeutics offer promise for enhancing both radiotherapy and immunotherapy, but their clinical translation is hindered by poor in vivo cle…
dual checkpoint blockadeSBRTtriple-negative breast cancerICITNBCimmune checkpoint inhibitor
… and exhausted subsets.Conclusions Compared to ICI monotherapy, dual checkpoint blockade targeting myeloid-derived inflammation can enhance antitumor im…
neoadjuvant IOimmunotherapynon-melanoma skin cancerresectable CSCCIONMSC
…s effective in improving practical K/C regarding integration of neoadjuvant IO into practice. The data also support the importance of reinforc…
combination therapysemaglutideSGLT2i
…or the significant association between hospitalization risk and combination therapy versus SGLT2i monotherapy, the corresponding E value was 1.36. …
Delayed treatment intensificationtype 2 diabetes mellitusUniversity of Gondar Comprehensive Specialised Hospitalretinopathycardioprotective medicationsdiabetic foot ulcernephropathyhypertensionheart failureneuropathy+1 more
…ng barriers to timely treatment intensification.Primary outcome Delayed treatment intensification.Results The prevalence of delayed treatment intensification was…